Literature DB >> 19003100

A regulatable selective system facilitates isolation of heterologous protein hyper-producing mammalian cells without gene amplification.

Kiichiro Teruya1, Yingpei Zhang, Yoshinori Katakura, Sanetaka Shirahata.   

Abstract

In this article, we describe a new method that facilitates to isolate mammalian cells inducible hyper-producing heterologous proteins. This method uses the tetracycline-inducible system to express both the selection marker and the heterologous gene, therefore, allows to increase the selection pressure by reducing the transcription of the selection maker gene. Using this method, we were able to isolate recombinant Chinese hamster ovary cells with a high efficiency. One of established clones produced the recombinant bovine beta-lactoglobulin as heterologous protein at a peak rate of 12 mug 10(-6) cells/day with an inducibility of about 100-fold. This clone was over expressed them RNA of beta-lactoglobulin and the drug resistant gene but did not amplify their genes. When cultured in a hollow fiber bioreactor, the cells were able to secrete beta-lactoglobulinover 300 mug ml(-1). This method is applicable to a broad range of eukaryotic systems and is of general value to technology for recombinant protein production.

Entities:  

Year:  2002        PMID: 19003100      PMCID: PMC3449528          DOI: 10.1023/A:1023945517446

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  An autocatalytic expression system for regulated production of recombinant protein in mammalian cells.

Authors:  Y Zhang; Y Katakura; H Ohashi; S Shirahata
Journal:  Anal Biochem       Date:  1997-10-15       Impact factor: 3.365

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

Authors:  Z Zhu; B Ma; R J Homer; T Zheng; J A Elias
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

6.  Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells.

Authors:  H V Le; L Ramanathan; J E Labdon; C A Mays-Ichinco; R Syto; N Arai; P Hoy; Y Takebe; T L Nagabhushan; P P Trotta
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

7.  Dicistronic transcription units for gene expression in mammalian cells.

Authors:  W Dirks; M Wirth; H Hauser
Journal:  Gene       Date:  1993-06-30       Impact factor: 3.688

8.  High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification.

Authors:  M I Cockett; C R Bebbington; G T Yarranton
Journal:  Biotechnology (N Y)       Date:  1990-07

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Productivity enhancement of recombinant protein in CHO cells via specific promoter activation by oncogenes.

Authors:  Y Katakura; P Seto; T Miura; H Ohashi; K Teruya; S Shirahata
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

View more
  1 in total

1.  A hybrid system using both promoter activation and gene amplification for establishing exogenous protein hyper-producing cell lines.

Authors:  Xiao-Yan Dong; Kiichiro Teruya; Yoshinori Katakura; Yingpei Zhang; Takumi Miura; Yoshihito Daimon; Tetsuya Mori; Hideya Ohashi; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.